Ramatroban

製品コードS5286 バッチS528601

印刷

化学情報

Chemical Structure Synonyms BAY u 3405 Storage
(From the date of receipt)		 3 years -20°C powder
1 years -80°C in solvent
化学式

C21H21FN2O4S
分子量 416.47 CAS No. 116649-85-5
Solubility (25°C)* 体外 DMSO 83 mg/mL (199.29 mM)
Ethanol 83 mg/mL (199.29 mM)
Water Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明 Ramatroban (BAY u 3405) is a thromboxane A2(TxA2) receptor antagonist with Ki value of 10 to 13 nM. It also antagonizes a newly identified PGD2 receptor, CRTh2 expressed on the inflammatory cells.
in vitro Ramatroban can block the PGD2 receptor, chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTh2). Ramatroban can suppress the expression of monocyte chemoattractant protein-1 (MCP-1) and adhesion molecules in endothelial cells and prevent exacerbation of inflammation by blocking these responses. It has inhibitory effects on platelet aggregation and vascular smooth muscle contraction. Ramatroban significantly inhibited binding of [3H]PGD2 to CRTh2 with an IC50 value of 100 nM. It also inhibited, in a concentration-dependent manner, PGD2-induced Ca2+ mobilization in CRTh2 transfectants with an IC50 = 30 nM and suppressed migration of human eosinophils induced by PGD2 with an IC50 = 170 nM[1].
in vivo In hypercholesterolemic rabbits, ramatroban prevents macrophage infiltration through MCP-1 downregulation and neointimal formation after balloon injury and attenuates vascular response to acetylcholine. The pharmacokinetic parameters after single oral administration of 75 mg ramatroban were studied in fasting healthy adult volunteers: relative bioavailability of ramatroban tablets (as compared with aqueous solution) was 80.3%. The pharmacokinetics of ramatroban at doses ranging from 25 to 150 mg was found to be linear. When a single dose of 50 mg of ramatroban was given orally to healthy volunteers postprandially, the AUC was 88.8% of that obtained in fasting state. A low total body clearance of ramatroban is shown in elderly subjects; After oral administration of [14C]ramatroban to male rats, maximum concentrations of radioactivity were higher in liver, kidneys and adipose tissues than in plasma. Other organs tissues had lower radioactivity levels than plasma. Radioactivity levels in most organs tissues declined in parallel with the decrease in the plasma radioactivity. In contrast, elimination of the radioactivity from the blood cells was relatively prolonged. Extremely low radioactivity levels were found only in the brain. The ratio of brain-to-plasma levels was as low as 8% at the maximum[1].

プロトコル(参考用のみ)

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。